SBIO

ALPS Medical Breakthroughs ETFALPS Funds$63.66-0.15 (-0.23%)

AUM $234.7MER 0.50%NAV $63.86Holdings 103Inception Dec 2014

Price Chart

Key Statistics

Previous Close

$63.80

Day Range

$63.40$64.97

52-Week Range

$35.64$70.79

Avg Volume

33.8K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$234.7M

Shares Outstanding

3.2M

ETF Grades

?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	88.70%
Canada	3.20%
United Kingdom	2.13%
Netherlands	1.65%
China	1.59%
Belgium	1.46%
Germany	0.71%
Switzerland	0.39%
Other	0.17%

Fund Information

Issuer: ALPS Funds
Category: Healthcare
Types: Healthcare
Inception Date: Dec 30, 2014
Exchange: NYSE_ARCA
Description: The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
SCHD	Schwab U.S. Dividend Equity ETF	$110.53B	0.06%	102
IWM	iShares Russell 2000 ETF	$77.55B	0.19%	1,957
XLV	State Street Health Care Select Sector SPDR ETF	$43.25B	0.08%	60
VHT	Vanguard Health Care ETF	$20.90B	0.09%	411
VTWO	Vanguard Russell 2000 ETF	$17.40B	0.06%	1,969

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $234.7M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 30.0% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	CGON	CG oncology Inc.	3.73%	121,532	$8.8M
2	TVTX	Travere Therapeutics Inc.	3.68%	128,099	$8.6M
3	XENE	Xenon Pharmaceuticals Inc.	3.34%	133,153	$7.8M
4	DNTH	Dianthus Therapeutics Inc.	3.31%	75,288	$7.8M
5	ORKA	Oruka Therapeutics Inc.	3.25%	83,137	$7.6M
6	ACAD	ACADIA Pharmaceuticals Inc.	2.79%	235,932	$6.5M
7	EWTX	Edgewise Therapeutics Inc.	2.71%	148,274	$6.4M
8	RLAY	Relay Therapeutics Inc.	2.42%	300,243	$5.7M
9	DFTX	Definium Therapeutics Inc.	2.42%	150,244	$5.7M
10	MANE	VeraDermics Inc.	2.41%	57,590	$5.7M
11	AMLX	Amylyx Pharmaceuticals Inc.	2.09%	153,131	$4.9M
12	TARS	Tarsus Pharmaceuticals Inc.	2.05%	59,248	$4.8M
13	DNLI	Denali Therapeutics Inc.	1.99%	218,682	$4.7M
14	IDYA	Ideaya Biosciences Inc.	1.93%	120,999	$4.5M
15	DYN	Dyne Therapeutics Inc.	1.79%	227,737	$4.2M

Page 1 of 3

Detailed Returns

Period	ETF	Cat. Avg
1D	-0.23%	—
1W	-6.46%	—
1M	-5.42%	—
3M	+18.30%	—
6M	+24.86%	—
YTD	+26.18%	—
1Y	+74.86%	—
3Y	+115.64%	—
5Y	+36.96%	—

Moving Averages

20-Day MA

$67.68

Below 20-Day MA

50-Day MA

$66.40

Below 50-Day MA

200-Day MA

$55.93

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$70.79

Current Price

$63.66

52-Week Low

$35.64

$35.64$70.79

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-Date	Amount	Pay Date
Dec 19, 2024	$1.1735	Dec 26, 2024
Dec 21, 2023	$0.0711	Dec 27, 2023
Dec 19, 2019	$0.0160	Dec 27, 2019
Dec 19, 2019	$0.0158	Dec 27, 2019
Dec 20, 2018	$0.7841	Dec 27, 2018
Dec 20, 2018	$0.7840	Dec 27, 2018
Dec 21, 2017	$0.5795	Dec 28, 2017
Dec 21, 2017	$0.5790	Dec 28, 2017

Dividend Payments Over Time

Category Comparison

Metric	SBIO	Healthcare(254 ETFs)	Healthcare(24 ETFs)
Fund Info
Expense Ratio	0.50%	0.62%	0.47%
AUM	$234.7M	$1.73B	$767.6M
Dividend Yield	2.29%	3.97%	1.61%
Avg Volume	33.8K	364.4K	91.3K
Holdings	103	160	171
Performance
1-Month Return	-5.93%	-2.86%	-2.51%
6-Month Return	+13.28%	+7.23%	+7.74%
YTD Return	+23.57%	+10.59%	+7.89%
1-Year Return	+25.54%	+8.50%	+7.55%

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.